Table 1.

Clinical and Biochemical Characteristics of Patients

Patients (P)	P1	P2	P3	P4	P5
Age (y)	56	62	74	61	56
Sex	male	male	male	male	male
Weight (Kg)	70	90	88	70	85
Infarct territory	Right MCA	Right carotid/Fetal PCA	Right MCA	Left MCA	Left MCA
Diabetes	Yes	No	No	Yes	No
Hypertension	Yes	No	No	Yes	No
Hyperlipidemia	Yes	No	yes	No	No
Recurrent stroke	No	Yes	-	No	No
Atrial Fibrilation	No	No	Yes	No	No
Smoker	No	No	Yes	No	No
Ischemic heart disease	No	No	Yes	No	No
MI	No	No	No	Yes	No
Endocarditis	Yes	No	No	No	No
Drinker	No	No	No	No	No
OSAS	No	No	No	No	No
Stroke subtype	Acute Ischemic	Acute Ischemic	Acute Ischemic	Acute Ischemic	Ischemic large vessel
Aspirin/clopidogel	No	Yes	Yes	Yes	No
ACE inhibitor or ARB	No	No	Yes	Yes	No
Ca2+channel blocker	No	No	No	No	No
Hypoglycemic agent	No	No	Yes	Yes	No
Time from onset to Exosome therapy, hours	4	30	36	15	27
rTPA	Yes	No	Yes	No	No
Pro-Coagulant drugs	No	No	Yes	No	No
Statin	yes	No	yes	yes	No
CRP	27.6	19.8	103.8	136.8	19.1
Bun/Cr	10/0.73	22/1.19	33/1.76	19/1.3	15/0.99
k	3.8	4.2	4.1	3.5	3.8
Na	135	141.7	128	143	140
INR	1	1.1	2.9	1.7	1.1/1
PTT	30	35	67	95	33/30
PT	13	14	25.7	18	13.7/13
Plt	281	325	174	139	186/226
Hb	11.7	13.6	7.6	9.7	10.9
WBC	10.6	19.4	17.1	8.9	5900/10000
ESR	40	25	25	80	23/110

OSAS, obstructive sleep apnea syndrome; ACE, angiotensin-converting enzyme; ARB, enzyme receptor blocker